- call +1-201-465-4211
- email sales@mrinsights.biz
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).
Scope of the Report:
North America is the largest consumption market of Overactive Bladder Treatment with prevalence as high as 11% and high medical level. In 2016, North America accounts for 49.59%.
Followed North America, Europe is the second largest consumption market with share of 27.84%. Besides, Japan is also an important market with market share over 17%. China and other Asian countries is the emerging market with the fastest growth rate, though there is no large manufacturer of Overactive Bladder Treatment drugs.
The Overactive Bladder Treatment market can be segmented as Anticholinergics, Mirabegron, Botox and Other Drugs. Among them, Anticholinergics account for the largest market share while it is in a decreasing trend. The growth rate of Mirabegron and Botox is fast.
The worldwide market for Overactive Bladder Treatment is expected to grow at a CAGR of roughly 5.4% over the next five years, will reach 6460 million US$ in 2024, from 4710 million US$ in 2019, according to a new study.
This report focuses on the Overactive Bladder Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Astellas Pharma
Allergan
Pfizer
Teva (Activas)
Johnson & Johnson
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Anticholinergics
Mirabegron
Botox
Market Segment by Applications, can be divided into
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Overactive Bladder Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Overactive Bladder Treatment, with price, sales, revenue and global market share of Overactive Bladder Treatment in 2017 and 2018.
Chapter 3, the Overactive Bladder Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Overactive Bladder Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Overactive Bladder Treatment market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Overactive Bladder Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Overactive Bladder Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Anticholinergics
1.2.2 Mirabegron
1.2.3 Botox
1.3 Market Analysis by Applications
1.3.1 Idiopathic Overactive Bladder
1.3.2 Neurogenic Overactive Bladder
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Astellas Pharma
2.1.1 Business Overview
2.1.2 Overactive Bladder Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Astellas Pharma Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Allergan
2.2.1 Business Overview
2.2.2 Overactive Bladder Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Allergan Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Overactive Bladder Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Teva (Activas)
2.4.1 Business Overview
2.4.2 Overactive Bladder Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Teva (Activas) Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Johnson & Johnson
2.5.1 Business Overview
2.5.2 Overactive Bladder Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Johnson & Johnson Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Overactive Bladder Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Overactive Bladder Treatment Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Overactive Bladder Treatment Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Overactive Bladder Treatment Manufacturer Market Share in 2018
3.3.2 Top 6 Overactive Bladder Treatment Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Overactive Bladder Treatment Market Analysis by Regions
4.1 Global Overactive Bladder Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Overactive Bladder Treatment Sales and Market Share by Regions (2014-2019)
4.1.2 Global Overactive Bladder Treatment Revenue and Market Share by Regions (2014-2019)
4.2 North America Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
4.3 Europe Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
4.5 South America Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
5 North America Overactive Bladder Treatment by Country
5.1 North America Overactive Bladder Treatment Sales, Revenue and Market Share by Country
5.1.1 North America Overactive Bladder Treatment Sales and Market Share by Country (2014-2019)
5.1.2 North America Overactive Bladder Treatment Revenue and Market Share by Country (2014-2019)
5.2 United States Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
5.3 Canada Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
5.4 Mexico Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
6 Europe Overactive Bladder Treatment by Country
6.1 Europe Overactive Bladder Treatment Sales, Revenue and Market Share by Country
6.1.1 Europe Overactive Bladder Treatment Sales and Market Share by Country (2014-2019)
6.1.2 Europe Overactive Bladder Treatment Revenue and Market Share by Country (2014-2019)
6.2 Germany Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
6.3 UK Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
6.4 France Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
6.5 Russia Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
6.6 Italy Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
7 Asia-Pacific Overactive Bladder Treatment by Country
7.1 Asia-Pacific Overactive Bladder Treatment Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Overactive Bladder Treatment Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Overactive Bladder Treatment Revenue and Market Share by Country (2014-2019)
7.2 China Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
7.3 Japan Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
7.4 Korea Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
7.5 India Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
8 South America Overactive Bladder Treatment by Country
8.1 South America Overactive Bladder Treatment Sales, Revenue and Market Share by Country
8.1.1 South America Overactive Bladder Treatment Sales and Market Share by Country (2014-2019)
8.1.2 South America Overactive Bladder Treatment Revenue and Market Share by Country (2014-2019)
8.2 Brazil Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
8.3 Argentina Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
8.4 Colombia Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
9 Middle East and Africa Overactive Bladder Treatment by Countries
9.1 Middle East and Africa Overactive Bladder Treatment Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Overactive Bladder Treatment Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Overactive Bladder Treatment Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
9.3 Turkey Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
9.4 Egypt Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
9.5 Nigeria Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
9.6 South Africa Overactive Bladder Treatment Sales and Growth Rate (2014-2019)
10 Global Overactive Bladder Treatment Market Segment by Type
10.1 Global Overactive Bladder Treatment Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Overactive Bladder Treatment Sales and Market Share by Type (2014-2019)
10.1.2 Global Overactive Bladder Treatment Revenue and Market Share by Type (2014-2019)
10.2 Anticholinergics Sales Growth and Price
10.2.1 Global Anticholinergics Sales Growth (2014-2019)
10.2.2 Global Anticholinergics Price (2014-2019)
10.3 Mirabegron Sales Growth and Price
10.3.1 Global Mirabegron Sales Growth (2014-2019)
10.3.2 Global Mirabegron Price (2014-2019)
10.4 Botox Sales Growth and Price
10.4.1 Global Botox Sales Growth (2014-2019)
10.4.2 Global Botox Price (2014-2019)
11 Global Overactive Bladder Treatment Market Segment by Application
11.1 Global Overactive Bladder Treatment Sales Market Share by Application (2014-2019)
11.2 Idiopathic Overactive Bladder Sales Growth (2014-2019)
11.3 Neurogenic Overactive Bladder Sales Growth (2014-2019)
12 Overactive Bladder Treatment Market Forecast (2019-2024)
12.1 Global Overactive Bladder Treatment Sales, Revenue and Growth Rate (2019-2024)
12.2 Overactive Bladder Treatment Market Forecast by Regions (2019-2024)
12.2.1 North America Overactive Bladder Treatment Market Forecast (2019-2024)
12.2.2 Europe Overactive Bladder Treatment Market Forecast (2019-2024)
12.2.3 Asia-Pacific Overactive Bladder Treatment Market Forecast (2019-2024)
12.2.4 South America Overactive Bladder Treatment Market Forecast (2019-2024)
12.2.5 Middle East and Africa Overactive Bladder Treatment Market Forecast (2019-2024)
12.3 Overactive Bladder Treatment Market Forecast by Type (2019-2024)
12.3.1 Global Overactive Bladder Treatment Sales Forecast by Type (2019-2024)
12.3.2 Global Overactive Bladder Treatment Market Share Forecast by Type (2019-2024)
12.4 Overactive Bladder Treatment Market Forecast by Application (2019-2024)
12.4.1 Global Overactive Bladder Treatment Sales Forecast by Application (2019-2024)
12.4.2 Global Overactive Bladder Treatment Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Overactive Bladder Treatment Picture
Table Product Specifications of Overactive Bladder Treatment
Figure Global Sales Market Share of Overactive Bladder Treatment by
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
